Parsons Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,005
Closed -$410K 429
2022
Q4
$410K Hold
1,005
0.03% 310
2022
Q3
$327K Buy
1,005
+5
+0.5% +$1.84K 0.03% 335
2022
Q2
$351K Hold
1,000
0.03% 332
2022
Q1
$547K Hold
1,000
0.04% 294
2021
Q4
$658K Hold
1,000
0.05% 273
2021
Q3
$622K Hold
1,000
0.05% 266
2021
Q2
$632K Hold
1,000
0.05% 264
2021
Q1
$489K Hold
1,000
0.04% 282
2020
Q4
$500K Hold
1,000
0.04% 262
2020
Q3
$393K Hold
1,000
0.04% 267
2020
Q2
$330K Hold
1,000
0.04% 267
2020
Q1
$242K Hold
1,000
0.03% 282
2019
Q4
$261K Hold
1,000
0.03% 309
2019
Q3
$272K Sell
1,000
-275
-22% -$76.5K 0.03% 301
2019
Q2
$351K Hold
1,275
0.04% 271
2019
Q1
$285K Sell
1,275
-125
-9% -$25.8K 0.03% 289
2018
Q4
$260K Hold
1,400
0.03% 288
2018
Q3
$350K Sell
1,400
-200
-13% -$48.5K 0.04% 289
2018
Q2
$349K Hold
1,600
0.04% 289
2018
Q1
$306K Sell
1,600
-200
-11% -$36.9K 0.04% 301
2017
Q4
$281K Sell
1,800
-200
-10% -$31.5K 0.03% 319
2017
Q3
$311K Hold
2,000
0.04% 296
2017
Q2
$323K Hold
2,000
0.04% 285
2017
Q1
$309K Hold
2,000
0.04% 285
2016
Q4
$235K Sell
2,000
-200
-9% -$22.8K 0.03% 303
2016
Q3
$248K Sell
2,200
-100
-4% -$10.5K 0.03% 292
2016
Q2
$214K Sell
2,300
-300
-12% -$25.8K 0.03% 309
2016
Q1
$204K Buy
+2,600
New +$187K 0.03% 312
2015
Q4
Sell
-3,000
Closed -$223K 332
2015
Q3
$223K Buy
+3,000
New +$215K 0.03% 309

Other funds holding IDXX

Parsons Capital Management's IDXX Position: Q1 2023 in Review

Parsons Capital Management sold out of Idexx Laboratories (IDXX) in Q1 2023, closing a stake of 1,005 shares — an estimated $410K sold.

Parsons Capital Management first reported a position in IDXX in Q3 2015 and held it in 29 quarters. The position peaked at $658K in Q4 2021. 1,055 funds tracked by Wall St. Rank hold IDXX as of Q1 2023.

  • Parsons Capital Management reported no remaining Idexx Laboratories position as of Q1 2023 after selling out during the quarter.
  • Parsons Capital Management sold 1,005 Idexx Laboratories shares in Q1 2023, an estimated $410K.
  • Parsons Capital Management first reported a position in Idexx Laboratories in Q3 2015 and held it in 29 quarters.
  • Parsons Capital Management's Idexx Laboratories position peaked at $658K in Q4 2021.
  • 1,055 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2023.

Based on Parsons Capital Management's 13F filing for Q1 2023, filed 17 Apr 2023.